GlassScriptPhysician profile
Shrikanth Upadya
NPI 1750492195
$42,694.34
in general payments reported to CMS, 2019-2025
38 companies · $7,148 in 2025
The $7,148 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $512 · 2021: $1,298 · 2022: $1,418 · 2023: $15K · 2024: $16K · 2025: $7,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $35K · Food and Beverage: $2,664 · Travel and Lodging: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $35,083.34 |
| Food and Beverage | $2,663.97 |
| Travel and Lodging | $779.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $35,339.86 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $2,285.98 | 2022-2024 | Indigo System, Penumbra System |
| Novartis Pharmaceuticals Corporation | $783.20 | 2019-2025 | |
| Cardiovascular Systems INC. | $689.72 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $554.01 | 2019-2022 | |
| Abbott Laboratories | $453.93 | 2022-2025 | Esprit, Jot Dx, Jeti |
| Amgen INC. | $351.64 | 2019-2025 | Repatha |
| Boston Scientific Corporation | $334.67 | 2019-2025 | Watchman Flx, Varithena Administration Pack, Resonate El Icd Vr |
| Astrazeneca Pharmaceuticals LP | $284.05 | 2019-2024 | Brilinta, Andexxa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $181.70 | 2020-2024 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $157.63 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $151.69 | 2020-2021 | |
| Pfizer INC. | $149.83 | 2019-2025 | |
| Reflow Medical INC | $94.38 | 2023 | |
| Sanofi-Aventis U.S. LLC | $92.84 | 2019-2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.68 | 2019-2023 | Jardiance |
| Bard Peripheral Vascular, INC. | $87.05 | 2020-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Impulse Dynamics (USA) INC. | $60.94 | 2021 | |
| Inari Medical, INC. | $56.04 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $53.01 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $45.87 | 2020-2025 | Camzyos |
| Medtronic, INC. | $36.80 | 2021-2022 | |
| Cordis US Corp. | $36.48 | 2023 | Mynx Control |
| Amarin Pharma, INC. | $30.71 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $28.26 | 2019 | |
| Bardy Diagnostics, INC. | $27.00 | 2020 | |
| Abiomed | $26.02 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.33 | 2023 | |
| Biosense Webster, INC. | $23.04 | 2019 | |
| Tactile Systems Technology INC | $22.85 | 2025 | Nimbl, Flexitouch Plus |
| Cardinal Health 200 LLC | $22.57 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $22.41 | 2021 | |
| Terumo Medical Corporation | $20.50 | 2021 | |
| Cook Medical LLC | $19.70 | 2019 | |
| Smith+Nephew, INC. | $18.12 | 2024 | Grafix Pl |
| Irhythm Technologies, INC. | $15.32 | 2020 | |
| Chiesi USA, INC. | $11.98 | 2019 | |
| Livanova USA, INC. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shrikanth Upadya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.